Proceedings of the National Academy of Sciences · 2017 · 91 citations · 44 references
Deregulated extracellular signal-regulated kinase (ERK) signaling drives cancer growth. Normally, ERK activity is self-limiting by the rapid inactivation of upstream kinases and delayed induction of dual-specificity MAP kinase phosphatases (MKPs/DUSPs). However, interactions between these feedback mechanisms are unclear. Here we show that, although the MKP DUSP5 both inactivates and anchors ERK in the nucleus, it paradoxically increases and prolongs cytoplasmic ERK activity. The latter effect is caused, at least in part, by the relief of ERK-mediated RAF inhibition. The importance of this spatiotemporal interaction between these distinct feedback mechanisms is illustrated by the fact that expression of oncogenic BRAF<sup>V600E</sup>, a feedback-insensitive mutant RAF kinase, reprograms DUSP5 into a cell-wide ERK inhibitor that facilitates cell proliferation and transformation. In contrast, DUSP5 deletion causes BRAF<sup>V600E</sup>-induced ERK hyperactivation and cellular senescence. Thus, feedback interactions within the ERK pathway can regulate cell proliferation and transformation, and suggest oncogene-specific roles for DUSP5 in controlling ERK signaling and cell fate.
44
Mutations of the BRAF gene in human cancer
Helen Davies, Graham R. Bignell, Charles Cox et al. · Nature · 2002 · 10.6K citations · Full text
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
Chong Sun, Liqin Wang, Sidong Huang et al. · Nature · 2014 · 896 citations · Full text
Glucose Deprivation Contributes to the Development of <i>KRAS</i> Pathway Mutations in Tumor Cells
Jihye Yun, Carlo Rago, Ian Cheong et al. · Science · 2009 · 895 citations · Full text
Senescence of human fibroblasts induced by oncogenic Raf
Jiyue Zhu, Douglas Woods, Martin McMahon et al. · Genes & Development · 1998 · 800 citations · Full text